Abzena

About:

Abzena is a biotechnology company that offers biologic and ADC products from concept to clinic.

Top Investors: Welsh Carson Anderson & Stowe, Catapult Ventures, Biospring Partners, ProVen VCT

Description:

Abzena is a biologics research partner. They provide biologic and ADC products from concept to clinic. They develop biologics and bioconjugates, and provides the solutions in integrated early discovery to mid-phase biotherapeutic and bioconjugation drug development and manufacturing in the biopharmaceutical industry.

Total Funding Amount:

$139M

Estimated Revenue Range:

$100M to $500M

Headquarters Location:

San Diego, California, United States

Founded Date:

2001-01-01

Contact Email:

info(AT)abzena.com

Founders:

Antony Godwin

Number of Employees:

501-1000

Last Funding Date:

2022-03-31

IPO Status:

Delisted

Industries: